Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PBYI | AMGN | VRTX | REGN | GSK |
| Company | Puma Biotechnology | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 4.13 | 314.41 | 444.72 | 980.42 | 45.06 |
| High | 4.83 | 315.81 | 447.85 | 985.00 | 45.19 |
| Low | 4.10 | 312.92 | 442.99 | 978.21 | 44.40 |
| Last | 4.46 | 313.42 | 447.29 | 983.03 | 44.73 |
| Change | +0.37 | +0.95 | +2.08 | +0.74 | -0.25 |
| % Change | +9.05% | +0.30% | +0.47% | +0.08% | -0.56% |
| Volume | 1,141,899 | 618,957 | 327,524 | 134,838 | 3,293,843 |
| 20-Day Average Volume | 414,886 | 2,833,191 | 1,068,494 | 444,823 | 3,460,857 |
| Previous Close | 4.10 | 312.47 | 445.21 | 982.29 | 44.98 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.81 | 295.65 | 414.78 | 943.41 | 43.46 |
| 20-Day Raw Stochastic | 36.51% | 84.18% | 98.98% | 94.80% | 77.75% |
| 20-Day Relative Strength | 43.63% | 64.24% | 72.86% | 61.26% | 63.73% |
| Weighted Alpha | +22.09 | +41.81 | +36.69 | +34.67 | +33.64 |
| Today's Opinion | 24% Sell | 72% Buy | 72% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 40% Sell | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Last Month's Opinion | 24% Buy | 56% Sell | 8% Buy | 24% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.59% since 05/13/24 | +1.67% since 05/13/24 | +4.02% since 05/13/24 | +0.62% since 05/13/24 | -0.95% since 05/13/24 |
| Low | 4.08 on 05/17/24 | 307.47 on 05/14/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 44.40 on 05/20/24 |
| High | 5.20 on 05/14/24 | 321.44 on 05/15/24 | 447.78 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 1-Month | |||||
| %Chg | -9.38% since 04/19/24 | +16.61% since 04/19/24 | +13.42% since 04/19/24 | +9.61% since 04/19/24 | +12.55% since 04/19/24 |
| Low | 4.08 on 05/17/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 39.96 on 04/22/24 |
| High | 5.34 on 04/23/24 | 322.60 on 05/03/24 | 447.78 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -33.14% since 02/20/24 | +10.61% since 02/20/24 | +6.32% since 02/20/24 | +3.82% since 02/20/24 | +6.47% since 02/20/24 |
| Low | 4.08 on 05/17/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 7.15 on 02/29/24 | 322.60 on 05/03/24 | 447.78 on 05/20/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +16.71% since 11/20/23 | +18.18% since 11/20/23 | +25.33% since 11/20/23 | +22.63% since 11/20/23 | +27.43% since 11/20/23 |
| Low | 3.62 on 12/01/23 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.13 on 11/22/23 |
| High | 7.73 on 02/15/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 197,539 | 167,619,840 | 114,887,776 | 108,234,592 | 93,218,352 |
| Shares Outstanding, K | 48,239 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 235,640,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | 21,590,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 43,770,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -4,820,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.31 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 05/02/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 13.36 | 16.89 | 29.26 | 26.08 | 11.11 |